Joshua A Kazam Allogene Therapeutics, Inc. (ALLO) insider trading activity

Joshua A Kazam is Director of Allogene Therapeutics, Inc.. Currently has a direct ownership of 350,763 shares of ALLO, which is worth approximately $431,438. The most recent transaction as insider was on Dec 18, 2025, when has been sold 47,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 351K

15.74% 3M change

15.74% 12M change

Total Value Held $431,438

Joshua A Kazam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2025	BUY Exercise of conversion of derivative security	-	47,700 Added 11.97%	350,763 Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	44,178 Added 12.72%	303,063 Common Stock
Mar 07 2022	SELL Bona fide gift	-	412,618 Reduced 61.45%	258,885 Common Stock
Mar 07 2022	BUY Other acquisition or disposition	-	412,618 Added 38.06%	671,503 Common Stock
Jan 12 2022	BUY Open market or private purchase	$189,000 $12.6 p/Share	15,000 Added 5.48%	258,885 Common Stock
Jun 11 2021	SELL Bona fide gift	-	500,000 Reduced 67.21%	243,885 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	-	16,498 Added 2.17%	743,885 Common Stock

Also insider at

KRON

Kronos Bio, Inc. Healthcare

TSIBW

Tishman Speyer Innovation Corp. II ETFs

Director

LTCH

Latch, Inc. Technology

JAK

Joshua A Kazam

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Value

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO

Account